Investigation of the mechanism of action of the lipolytic agent 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956).
D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D004950:Esterases / Q000037:antagonists & inhibitors; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism*; D005990:Glycerol / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000494:pharmacology
D005230:Fatty Acids, Nonesterified; D007093:Imidazoles; D009539:Nicotinic Acids; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D004950:Esterases; D000262:Adenylyl Cyclases; D005990:Glycerol; D009638:Norepinephrine